|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||0.0440 - 0.0540|
|52 Week Range||0.0005 - 0.1580|
|Beta (3Y Monthly)||73.10|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Destroys on first pass more than 99.97% of harmful airborne viruses and bacteria. Inactivates pathogens that cause measles, the common cold, MRSA (staph), whooping cough, TB, pneumonia and other antibiotic-resistant and viral infections.
Features longer-lasting, more effective UV light for more efficient inactivation of viruses and bacteriaRxAir available for medical, business and residentialRxAir now available.
Sustainably sourced Vytex latex for ultra-long life, yet completely biodegradable. WORCESTER, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Vystar® Corporation (VYST) today began the New England soft launch of Vytex® Cloud Bed-in-a-Box Collection of 100% all natural latex mattresses in three levels of support. The Bed-in-a-Box concept is a hit with consumers - transforming the $30 billion dollar a year mattress industry. Industry Bed-in-a-Box sales grew by 60% in 2017. In a society that is now comfortable with online sales and enjoys the convenience of to your door delivery, Bed-in-a-Box sales now account for nearly 30% of all mattress sales.
Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that the board has authorized a stock buyback plan of up to 250 million shares, which represents approximately half of the outstanding shares, and has paid off a $105,000 convertible note in cash to limit dilution. Vystar paid off the remaining outstanding Peak One convertible note, due January 22, 2019 for $105,000 in cash on December 19th, 2019.